Kelly Brown: Associate Professor at Department of Pediatrics, UBC Faculty of Medicine

Associate Professor

Faculty of Medicine

Research Classification

Medical, health and life sciences

Research Interests

childhood rheumatic diseases

Inflammation

phagocytes

Relevant Thesis-Based Degree Programs

View all programs

Affiliations to Research Centres, Institutes & Clusters

BC Children's Hospital Research Institute

Centre for Blood Research

Research Options

I am available and interested in collaborations (e.g. clusters, grants).

I am interested in and conduct interdisciplinary research.

Open All

Biography

In Canada, rheumatic conditions are the most common chronic illness of childhood, affecting as many as 10 000 of our children and youth. Examples of rheumatic diseases are juvenile idiopathic arthritis, lupus, vasculitis and autoinflammatory conditions. The common denominator for all is pain and / or inflammation in joints, muscles, and critical organs. Some diseases are life- or organ- threatening and all have significant potential for lifelong poor health and disability. There are no cures and remarkably few treatments that are specific and safe for a growing child. My research program is designed to generate an evidence base for clinical decisions that ultimately improve outcomes for Canadian children and families affected by rheumatic disease.

Research Methodology

Flow cytometry, ELISA, qPCR, Immunoblotting, cell culture, R statistical language, biostatistical modeling

Recruitment

Looking to recruit:

Doctoral students

Postdoctoral Fellows

Desired start dates: 2024

Potential research project areas:

We are a highly collaborative, multidisciplinary team of scientists that are motivated to improve diagnosis, treatment and outcomes for children and youth with a rheumatic disease through the discovery of driving mechanisms and prognostic biomarkers. Priority rheumatic diseases are: vasculitis - which develops when blood vessels carring oxygen to critical organs in the body (inclusive of the brain, kidneys and lungs) are damaged by inflammation, and systemic autoinflammatory diseases (SAID) - which are caused by unprovoked, recurrent and uncontrolled attacks of inflammation and fever. Specifically, trainees work towards the i) validation and prospective testing of biomarkers for diagnosis and assessment of overall and organ-specific disease activity, and ii) unravel the contribution of innate and adaptive processes to disease onset, severity, and response to treatment.

Ideal Applicant Profile:

Ideal team members are basic scientists (BSc, MSc, PhD) that are passionate about improving child health through a translational, 'team science' approach. They may have foundational training in a variety of scientific disciplines (immunology, biochemistry, genetics, computing science). Individuals should be highly motivated and have prior research experience. Strong interpersonal skills and the ability to communicate with scientists, clinicians and patients/families is essential.

All researchers based at the BC Children's Hospital require a Criminal Record Check (CRC) and must provide proof of full vaccination against COVID-19. We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, or Indigenous person.

Other options:

I support public scholarship, e.g. through the Public Scholars Initiative, and am available to supervise students and Postdocs interested in collaborating with external partners as part of their research.

I support experiential learning experiences, such as internships and work placements, for my graduate students and Postdocs.

I am open to hosting Visiting International Research Students (non-degree, up to 12 months).

I am interested in supervising students to conduct interdisciplinary research.

Complete these steps before you reach out to a faculty member!

Check requirements

Familiarize yourself with program requirements. You want to learn as much as possible from the information available to you before you reach out to a faculty member. Be sure to visit the graduate degree program listing and program-specific websites.
Check whether the program requires you to seek commitment from a supervisor prior to submitting an application. For some programs this is an essential step while others match successful applicants with faculty members within the first year of study. This is either indicated in the program profile under "Admission Information & Requirements" - "Prepare Application" - "Supervision" or on the program website.

Focus your search

Identify specific faculty members who are conducting research in your specific area of interest.
Establish that your research interests align with the faculty member’s research interests.
- Read up on the faculty members in the program and the research being conducted in the department.
- Familiarize yourself with their work, read their recent publications and past theses/dissertations that they supervised. Be certain that their research is indeed what you are hoping to study.

Make a good impression

Compose an error-free and grammatically correct email addressed to your specifically targeted faculty member, and remember to use their correct titles.
- Do not send non-specific, mass emails to everyone in the department hoping for a match.
- Address the faculty members by name. Your contact should be genuine rather than generic.
Include a brief outline of your academic background, why you are interested in working with the faculty member, and what experience you could bring to the department. The supervision enquiry form guides you with targeted questions. Ensure to craft compelling answers to these questions.
Highlight your achievements and why you are a top student. Faculty members receive dozens of requests from prospective students and you may have less than 30 seconds to pique someone’s interest.
Demonstrate that you are familiar with their research:
- Convey the specific ways you are a good fit for the program.
- Convey the specific ways the program/lab/faculty member is a good fit for the research you are interested in/already conducting.
Be enthusiastic, but don’t overdo it.

Attend an information session

G+PS regularly provides virtual sessions that focus on admission requirements and procedures and tips how to improve your application.

ADVICE AND INSIGHTS FROM UBC FACULTY ON REACHING OUT TO SUPERVISORS

These videos contain some general advice from faculty across UBC on finding and reaching out to a potential thesis supervisor.

Graduate Student Supervision

Doctoral Student Supervision

Dissertations completed in 2010 or later are listed below. Please note that there is a 6-12 month delay to add the latest dissertations.

Assessment of biological markers to aid subtype classification in pediatric primary systemic vasculitis (2023)

Chronic primary systemic vasculitis (PSV) describes a diverse group of debilitating and potentially life-threatening diseases, characterized by inflammation of blood vessels within various organs such as the kidneys, lungs, brain, eyes, and skin. Subtypes of the small- to medium-sized vessel vasculitides are particularly challenging to classify due to many overlapping clinical symptoms. Their differentiation is important, however, as there is evidence that different subtypes benefit from different treatment approaches. The rarity of vasculitis in children has limited pediatric-specific PSV studies and the clinical approach to pediatric PSV is adapted primarily from adult studies. Not surprisingly, adult-derived classification criteria are imperfect for children and consequently, fail to classify up to two thirds of children with small- to medium-vessel PSV. The objective of this dissertation is to identify genetic markers and select, circulating biomarkers to better our understanding and clinical approach to managing the disease and to improve outcomes of children with chronic PSV. Using biological samples and clinical metadata from a worldwide cohort of children with chronic PSV, this dissertation reports (1) genetic associations specific to pediatric autoimmune vasculitis through employing a genome-wide association study; (2) a high prevalence of autoantibodies to lysosome associated membrane protein-2 in pediatric PSV that correlate to vasculitis-associated kidney dysfunction; and (3) the identification of nine patients, originally diagnosed with chronic PSV, harbouring novel and/or rare variants in adenosine deaminase 2 (ADA2) – these genetic data alongside having abrogated ADA2 enzyme activity have led to their reclassification as having a new monogenic form of vasculitis, deficiency of adenosine deaminase 2. This dissertation reports the first large-scale genotype and biomarker study of primary vasculitis focusing solely on pediatric cases. Improved classification is critical for timely therapeutic intervention, for identification of appropriately classified children for clinical trials, and for research, all of which will improve our understanding of the disease and the quality of life of children suffering from chronic PSV.

View record

Hyaluronan-mediated modulation of human neutrophil function (2023)

Hyaluronan (HA) is a glycosaminoglycan that in its natural, high molecular mass (HMM) form, promotes tissue repair and homeostasis. With inflammation, enhanced HA metabolism results in HMM HA fragmentation to low molecular mass (LMM) fragments that may act as a damage-associated molecular pattern to initiate innate immune responses. However, the responsiveness of myeloid cells to HA is controversial and largely unknown for neutrophils. Here, I investigated if and how HA can directly affect key immune functions of neutrophils and potentially contribute to the dysregulated neutrophil activation observed in childhood-onset rheumatic diseases. For this investigation, peripheral blood cells from healthy donors were incubated ex vivo with pharmaceutical grade HA of different molecular mass (HMM, LMM and HA fragments
View record

Master's Student Supervision

Theses completed in 2010 or later are listed below. Please note that there is a 6-12 month delay to add the latest theses.

Platelet factor 4 (PF4), a potential biomarker for disease activity in juvenile idiopathic arthritis (JIA) (2022)

Juvenile idiopathic arthritis (JIA) is the most common cause of youth disability in Canada, characterized by chronic joint inflammation and bone degradation. Common JIA treatment regimens include nonsteroidal anti-inflammatory drugs (NSAIDs), and disease-modifying agents. Currently, there are no reliable means to identify those children with JIA at risk of a more severe or progressive or frequently relapsing disease. Platelets are blood cells with well characterized roles in hemostasis and increasingly recognized contributions to inflammation in chronic inflammatory disease. Specifically, the presence of platelet factor 4 (the most abundant platelet-derived chemokine) and activated platelets have been associated with inflammation in rheumatoid joints in adults. However, the role of platelet-derived proteins in juvenile arthritis has not yet been evaluated. This patient-based study evaluated platelet factor 4 (PF4) as a potential subclinical marker of disease activity in JIA and explored a possible cross-talk with neutrophils and neutrophil-derived S100A proteins (S100A8/9 and S100A12) that have been shown to track with JIA disease activity. Results demonstrated that intracellular (within platelets) and extracellular (in plasma) PF4 was significantly more abundant in healthy children compared to adults, and release of PF4 from thrombin receptor-activated platelets was enhanced with prior exposure to S100A12 and S100A8/9. In contrast, PF4 did not stimulate pro-inflammatory responses (release of reactive oxygen species or S100A protein) by neutrophils. Early in JIA disease course and in the absence of NSAID treatment, there was a moderate correlation between circulating concentrations of PF4 and both disease activity and concentrations of S100A12. For patients in remission, circulating PF4 concentrations were higher in children who relapsed, correlated with the time to first flare, and had a similar probability of predicting a flare compared to S100A12. Overall, this study helped to advance our understanding of the role of platelets in chronic inflammation and provided preliminary evidence for PF4 as a subclinical marker for JIA disease activity.

View record